Have a personal or library account? Click to login
Modulation of microglial function by the antidepressant drug venlafaxine 28 November 2014 Cover

Modulation of microglial function by the antidepressant drug venlafaxine 28 November 2014

Open Access
|Mar 2015

Abstract

An increasing amount of data suggests that depression is an inflammatory disease. Depressed patients have higher peripheral blood levels of inflammatory markers which have been shown to access the brain and interact with the pathophysiological domain known to be involved in depression. Furthermore, microglia activation may play an important role in the inflammatory pathophysiology of depression.

In BV-2 microglia cell line, the present study investigated the potential anti-inflammatory effects of venlafaxine, along with its potential influence on injury of lipopolysaccharide (LPS)-stimulated cells. Although venlafaxine showed only marginal influence on the majority of the pro-inflammatory parameters assessed (in particular NO release, phagocytosis and proliferation), it significantly suppressed superoxide production by the stimulated cells. In addition, venlafaxine exerted also a protective effect on mitochondrial membrane potential and lysosomes of the stimulated microglia.

In conclusion, our results suggest that although VEN might have only a marginal effect on major pro-inflammatory parameters of microglia, its inhibitory effect on superoxide generation can contribute to the prevention of harmful effects of oxidative and nitrosative stress involved in the pathogenesis of depression. Moreover, the protective effect of VEN on viability of microglia can prevent a rapid reduction of these cells, thus avoiding limitations of several physiological processes in the brain and possibly also the progression of depression

DOI: https://doi.org/10.2478/intox-2014-0029 | Journal eISSN: 1337-9569 | Journal ISSN: 1337-6853
Language: English
Page range: 201 - 207
Submitted on: Nov 2, 2014
|
Accepted on: Nov 29, 2014
|
Published on: Mar 4, 2015
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2015 Michal Dubovický, Eszter Császár, Kristína Melicherčíková, Marcela Kuniaková, Lucia Račková, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.